Androgen receptor (AR) is known to be a tumor suppressor in ER+ breast cancer type [20] is one of the predictor belonging to cluster G (Fig. 3b) and is not expressed in ER+ cells (Fig. 3a and b) but expressed in BC07LN (metastasized triple negative TNBC cells). This evidence concerns the gene ESR1 and breast carcinoma.